The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

To delete your data from 23andMe, you need to log in to your account and then follow these steps: Navigate to the Settings ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Anne Wojcicki has been declared the winner of a bankruptcy auction for 23andMe, the genetics testing start-up she founded, ...

Anne Wojcicki's nonprofit is set to purchase all significant assets of the bankrupt genetic testing company, 23andMe, for ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on Friday. 23andMe filed for for Chapter 11 bankruptcy protection in March. Last ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.